drugset / Trial / NCT01650519

A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery

NCT01650519

Phase 4 Completed 51 enrolled Cumberland Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

The intent of this study is to assess the analgesic efficacy of IV ibuprofen when administered at induction of anesthesia. Results from this pilot study will be used to design and determine the appropriate statistical power for a larger, multi-center randomized study.

Timeline

Start
2012-09
Primary completion
2012-12
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 800 mg Intravenous
Comparator Ketorolac Other / unclassified 15 mg Intravenous
Comparator Ketorolac Other / unclassified 30 mg Intravenous

Indications

No indication recorded.